previously treated Myelodysplastic Syndromes (MDS)

DBCOND0153828Hemic and Lymphatic Diseases Neoplasms

previously treated Myelodysplastic Syndromes (MDS) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as: Previously Treated Myelodysplastic Syndromes · Previously Treated Myelodysplastic Syndrome · Myelodysplastic Syndromes, Previously Treated
Classified under: Hemic and Lymphatic Diseases
Neoplasms
Indicated drugs: Cedazuridine
Decitabine

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

116Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for previously treated Myelodysplastic Syndromes (MDS) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account